Form 4: Chardan Capital Markets Sells Shares of ANEW Medical, Reducing Stake

Sentiment:

SEC Form 4 Filing


Chardan Capital Markets LLC, along with related individuals, sold a significant number of ANEW Medical, Inc. shares over several transactions, reducing their beneficial ownership.

Worse than expectedChardan Capital Markets LLC sold a significant number of shares, reducing their stake in ANEW Medical, which could be interpreted negatively by the market.

Summary

  • Chardan Capital Markets LLC (CCM) and related individuals, including Jonas Grossman, Steven Urbach, and Kerry Propper, filed a Form 4 detailing changes in their beneficial ownership of ANEW Medical, Inc. (WENA) common stock.
  • On June 28, 2024, CCM sold 47,000 shares at a weighted average price of $2.5341 per share.
  • On July 1, 2024, CCM sold 115,136 shares at a weighted average price of $2.0638 per share.
  • On July 2, 2024, CCM sold 180,000 shares at a weighted average price of $2.0469 per share.
  • Following these transactions, CCM's direct ownership decreased from 1,579,500 to 1,284,364 shares.
  • Chardan Securities LLC, as the sole Class A Member and 99% owner of CCM, may be deemed to have beneficial ownership of the shares held by CCM.
  • Grossman, Urbach, and Propper, as members of Chardan Securities, also may be deemed to have beneficial ownership but disclaim any beyond their pecuniary interest.

Sentiment

Score: 3

Explanation: The document indicates a significant shareholder is reducing their position, which is generally viewed negatively by the market. The sentiment is therefore leaning towards negative.

Negatives

  • The sales by Chardan Capital Markets LLC represent a reduction in their stake in ANEW Medical, which could be interpreted negatively by the market.

Risks

  • Continued sales by Chardan Capital Markets LLC could further depress the stock price of ANEW Medical.
  • The market may react negatively to the reduced ownership stake of a significant shareholder.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. These filings provide transparency into the transactions of those with privileged information and can influence investor sentiment.

Stakeholder Impact

  • Shareholders may react to the news of Chardan Capital Markets LLC's reduced stake.
  • The market price of ANEW Medical, Inc. could be affected by these transactions.

Key Dates

DateDescription
06/28/2024Chardan Capital Markets LLC sold 47,000 shares of ANEW Medical, Inc.
07/01/2024Chardan Capital Markets LLC sold 115,136 shares of ANEW Medical, Inc.
07/02/2024Chardan Capital Markets LLC sold 180,000 shares of ANEW Medical, Inc.
07/02/2024Form 4 filing date.

Keywords

ANEW Medical, Chardan Capital Markets, Form 4, Beneficial Ownership, Share Sales, WENA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.